Directed evolution of high-affinity antibody mimics using mRNA display.

Area of Science:

• Biotechnology
• Protein Engineering
• Immunology

Background:

• Antibody mimics offer alternatives to traditional antibodies.
• The tenth fibronectin type III domain (10Fn3) is a versatile protein scaffold.
• mRNA display is a powerful technique for in vitro protein evolution.

Purpose of the Study:

• To create high-affinity antibody mimics targeting TNF-alpha.
• To explore the utility of 10Fn3 scaffolds and mRNA display for protein engineering.
• To assess the potential of these mimics in diagnostic and therapeutic applications.

Main Methods:

• Construction of a large library (>10^12) of randomized 10Fn3 variants.
• Isolation of TNF-alpha binding proteins using iterative mRNA display selection.
• Affinity maturation to enhance binding characteristics.
• Validation of binding using protein microarrays.

Main Results:

• Isolation of 10Fn3 variants with dissociation constants (K(d)) in the nanomolar range (1-24 nM) for TNF-alpha.
• Achieved a lowest K(d) of 20 pM after affinity maturation.
• Demonstrated successful capture of TNF-alpha using immobilized antibody mimics.
• Established the efficacy of 10Fn3 scaffolds and mRNA display for generating high-affinity binders.

Conclusions:

• 10Fn3-based scaffolds combined with mRNA display enable the isolation of potent antigen-binding proteins.
• Engineered antibody mimics show promise for TNF-alpha targeting.
• Potential applications include advanced diagnostic protein microarrays and novel protein therapeutics.